Parker Laboratories Launches World’s First Barrier and Securement Dressing
By MedImaging International staff writers Posted on 25 Jun 2018 |
Image: The UltraDrape UGPIV Barrier and Securement dressing is designed for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) procedures (Photo courtesy of Parker Laboratories).
Parker Laboratories, Inc. (Fairfield, NJ, USA), a manufacturer of accessories and supplies for the ultrasound and electromedical markets, has launched UltraDrape UGPIV Barrier and Securement, the first-of-its-kind, uniquely designed dressing for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) procedures.
Parker Laboratories manufactures and markets ultrasound and electromedical contact media, as well as institutional cleaners and disinfectants. The company also engages in special contract manufacturing projects to meet the special circumstances of its customers and provides assistance in the development of customized formulations and/or packaging to meet the most stringent special requirements of the industry.
Parker Laboratories’ new UltraDrape features dual-action dressing to address the challenges that often arise with UGPIV such as extended procedure times, securement failure as a result of inadequate gel removal, and increased risk of infection. UltraDrape is designed to be user-friendly and facilitate a no-touch aseptic procedure without compromising efficacy or impeding visualization. The film layer used during ultrasound guidance is easily discarded, eliminating the need to clean transmission gel from the skin. In addition to minimizing post-IV procedure cleanup time, UltraDrape helps reduce procedure cost when compared with sterile gels and covers.
“UltraDrape represents an unprecedented advancement enabling UGPIV practitioners to perform procedures efficiently, effectively, and at a significant cost savings when compared with use of sterile gels and covers,” said Neal Buchalter, president of Parker Laboratories.
Parker Laboratories manufactures and markets ultrasound and electromedical contact media, as well as institutional cleaners and disinfectants. The company also engages in special contract manufacturing projects to meet the special circumstances of its customers and provides assistance in the development of customized formulations and/or packaging to meet the most stringent special requirements of the industry.
Parker Laboratories’ new UltraDrape features dual-action dressing to address the challenges that often arise with UGPIV such as extended procedure times, securement failure as a result of inadequate gel removal, and increased risk of infection. UltraDrape is designed to be user-friendly and facilitate a no-touch aseptic procedure without compromising efficacy or impeding visualization. The film layer used during ultrasound guidance is easily discarded, eliminating the need to clean transmission gel from the skin. In addition to minimizing post-IV procedure cleanup time, UltraDrape helps reduce procedure cost when compared with sterile gels and covers.
“UltraDrape represents an unprecedented advancement enabling UGPIV practitioners to perform procedures efficiently, effectively, and at a significant cost savings when compared with use of sterile gels and covers,” said Neal Buchalter, president of Parker Laboratories.
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures